GENE ONLINE|News &
Opinion
Blog

European Commission
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
The First Approved RSV Vaccine Worldwide Belongs to AstraZeneca and Sanofi
2022-11-06
Merck’s Streptococcus pneumoniae Expansion Finally Receives European Commission Approval
2022-10-24
Kite’s Yescarta Climbs Up To Treat Second-Line B-Cell Lymphomas After EC Nod
2022-10-18
AstraZeneca’s Rare Disease Treatment Wins Third Approval in European Union
2022-09-23
BridgeBio and Sentynl Therapeutics’ Nulibry Gets Greenlighted In Europe
2022-09-21
AstraZeneca’s Treatment for COVID-19 Wins European Approval
2022-09-20
Aurinia Wins Approval For Lupus Nephritis Therapy In Europe
2022-09-20
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
Novartis’ Treatment for Rare Cancer Wins European Commission’s Approval
2022-08-29
Johnson & Johnson’s Multiple Myeloma Treatment Wins Accelerated Approval
2022-08-24
Kyowa Kirin’s Treatment for a Rare Cancer Disorder Approved by European Commission
2022-08-19
CHMP Recommends Approval for Bristol Myers Squibb First-Line Treatment for Advanced Melanoma
2022-07-25
Sanofi’s New Pompe Disease Treatment Wins Approval in Europe
2022-06-29
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
1 2
LATEST
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Amgen Faces Class Action Lawsuit for Concealing $10.7 Billion Tax Bill to Manipulate Stock Price
2023-03-16
ImmunoPrecise Antibodies, Libera Bio Ink $155 Million Pact To Deliver Antibodies With Nanotechnology
2023-03-16
Dermavant Eyes Second Vtama Indication with Topline Atopic Dermatitis Results
2023-03-15
Scroll to Top